Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effect of Teriparatide With Bisphosphonate or Denosumab
NCT01750086Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2013
- Primary completion
- Apr 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in postmenopausal osteoporosis, sponsored by Massachusetts General Hospital. Started Jan 2013; status: completed.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT01750086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01750086.